Early-life EBV infection protects against persistent IgE sensitization.
BACKGROUND
Infection with EBV has previously been implicated in influencing allergic disorders, but its precise role remains contradictory. The timing of primary infection may contribute to the discrepancies.


OBJECTIVE
This study aimed at investigating whether the time-point of primary EBV infection during childhood could be of importance in modulating the risk of developing IgE sensitization.


METHODS
A total of 219 Swedish infants were followed prospectively to 5 years of age with clinical examinations, skin prick testing, specific IgE analyses, and determination of serostatus against EBV.


RESULTS
After analysis of the children's EBV serostatus, we found that 5-year-olds who were infected with EBV before the age of 2 years were at a significantly lower risk of being persistently IgE-sensitized-that is, sensitized at both 2 and 5 years of age (adjusted odds ratio, 0.34; 95% CI, 0.12-0.94). In contrast, contraction of EBV after 2 years of age was highly associated with late-onset IgE sensitization (adjusted odds ratio, 4.64; 95% CI, 1.57-13.69). Persistently sensitized 5-year-olds had higher specific-IgE levels than children with late-onset IgE sensitization (P < .01).


CONCLUSIONS
Our data support the value of early-life microbial exposure for protection against the development of IgE sensitization and underscore the proximate postnatal years as an important period during which EBV could contribute to an allergo-protective immune profile.
Saghafian-Hedengren
Shanie
S
Department of Immunology, Wenner-Gren Institute, Stockholm University, 10691-Stockholm, Sweden. shanie@imun.su.se
Sverremark-Ekström
Eva
E
Linde
Annika
A
Lilja
Gunnar
G
Nilsson
Caroline
C
D017668:Age of Onset; D000914:Antibodies, Viral / Q000097:blood / Q000276:immunology; D002675:Child, Preschool; D020031:Epstein-Barr Virus Infections / Q000276:immunology*; D005260:Female; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology*; D007073:Immunoglobulin E / Q000097:blood / Q000276:immunology*; D008297:Male; D012882:Skin Tests
D000914:Antibodies, Viral; D007073:Immunoglobulin E